The loss of NRF2 in oligodendrocytes may contribute to cognitive decline

**Research in humans and mice suggests that changes in oligodendrocytes and myelin may contribute to age-related cognitive decline.

• The worst cognitive trajectories were associated with smaller myelinated axons, thicker myelin, and lower expression of NRF2.
• Oligodendrocytes maintain the myelin sheaths that allow for efficient impulse transmission between neurons.
• Mice with specific deletion of NRF2 in oligodendrocytes showed attenuated cognitive improvement over time.

A study published in Nature Medicine places oligodendrocytes, the cells responsible for maintaining myelin in the brain, at the center of a possible explanation for age-related cognitive decline. The work links the worst cognitive trajectories with unexpected changes in myelinated axons, thicker myelin, and downregulation of NRF2, a molecular pathway that researchers propose as a potential therapeutic target.

The finding does not present the loss of myelin as a simple process nor does it conclude that NRF2 is, by itself, the cause of mental deterioration. Its significance lies in combining neuropathological and transcriptomic observations in human white matter with an experiment in mice that specifically eliminated NRF2 in oligodendrocytes, providing an experimental connection between these cellular changes and cognitive performance.

The function of oligodendrocytes

Oligodendrocytes are resident cells of the central nervous system that produce and maintain the myelin sheaths around neuronal axons. These structures function as an insulating layer: they help electrical impulses travel quickly and efficiently between neurons and provide support to axons.

When myelin loses integrity, neuronal communication can become less efficient and contribute to various debilitating conditions. Aging also brings a certain degree of white matter deterioration, although for years the question remained open as to how much of that process truly explains individual differences in memory, learning, and other cognitive abilities.

Learning adds another dimension to the problem, as it has been established in mice that acquiring knowledge requires an increase in oligodendrocytes through de novo generation. In humans, learning during youth and adulthood is associated with an increase in central nervous system myelin, reinforcing the idea that these cells are not merely structural elements but active participants in brain adaptation.

Previous studies in aged mice and non-human primates had linked cognitive decline with a reduction in oligodendrocytes and myelin. However, the abnormalities observed through magnetic resonance imaging in the white matter of older individuals did not, by themselves, reveal what was happening inside those cells or how their changes could modify each individual's cognitive trajectory.

An unexpected pattern in white matter

The study analyzed neuropathological and transcriptomic changes in human white matter to seek associations with individual rates of cognitive decline during aging. The most striking result was that the worst trajectories were not solely linked to a lower amount of myelin or insufficient remyelination, but to a more complex combination of alterations in axons, sheaths, and oligodendrocytes.

Specifically, researchers observed that poorer cognitive performance over time was associated with smaller sizes of myelinated axons and thicker myelin. This combination challenges the intuition that a more abundant insulating layer necessarily improves neuronal conduction, as the thickness and organization of myelin may reflect a dysfunctional cellular response rather than more effective protection.

The same group also identified a greater presence of oligodendrocytes with downregulated NRF2 among cases showing less favorable cognitive trajectories. The source does not present this association as definitive proof of causality in humans, but the pattern gains weight because it was accompanied by a specific manipulation of the pathway in an animal model.

NRF2 thus appears as a signal linked to the functional state of oligodendrocytes and not merely as a general marker of brain aging. The therapeutic interest suggested by the researchers would depend on confirming whether restoring or preserving this pathway can improve the response of these cells, maintain the quality of myelin, and protect communication between neurons.

The Experiment with Mice

To test the relationship between NRF2 and cognition, researchers used aged mice with a specific knockout of NRF2 in oligodendrocytes. This design is relevant because it concentrates the alteration in the myelin-producing cells, rather than indiscriminately modifying all tissues or cell types in the nervous system.

Animals with this knockout showed an attenuated cognitive improvement over time, a behavior that reflected the pathology of white matter associated with human cognitive decline during aging. The result supports the possibility that the loss of NRF2 regulation in oligodendrocytes actively contributes to the evolution of deterioration, although it does not automatically make the mouse model a complete explanation of human disease.

The comparison between modified animals and patterns observed in humans allowed researchers to connect a molecular alteration with changes in the structure of white matter and a less favorable cognitive trajectory. This convergence is important because brain aging often involves multiple simultaneous processes, from cellular changes to modifications in connectivity and energy support for neurons.

The experiment also helps to nuance a common interpretation of remyelination. The problem does not seem to consist solely of oligodendrocytes producing less myelin after an injury or during old age, but rather that they may change their behavior, alter the architecture of the sheaths, and lose part of the regulation necessary to sustain functional axons.

Implications and Limits of the Finding

The results position oligodendrocytes as possible direct contributors to cognitive decline, rather than treating them as passive spectators of neuronal damage initiated elsewhere. If the NRF2 pathway plays the suggested role, future strategies could attempt to preserve its activity within these cells to sustain the integrity of white matter during aging.

However, the proposal still belongs to the realm of research and does not constitute a therapy available for older adults. The work shows associations in human tissue and effects of genetic manipulation in mice, but it would still be necessary to determine whether the same mechanisms operate with equal intensity in humans, what interventions can safely modulate NRF2, and what would be the appropriate timing to apply them.

It will also be important to establish how NRF2 interacts with other processes related to brain aging. Myelin depends on the activity of oligodendrocytes, the state of the axons, and the environment of the white matter, so a future intervention will likely need to consider the relationship between cellular metabolism, neuronal support, and repair capacity, rather than pursuing a single molecular indicator.

For now, the study provides a more precise explanation for a known observation: white matter anomalies are related to cognitive decline, but imaging alone does not tell the whole story. By identifying specific changes in oligodendrocytes and linking them to NRF2, the research opens a pathway to understand why some brains age with more resilient cognitive trajectories than others.

The main conclusion is that aged myelin should not be evaluated solely by its quantity or the possibility of regenerating it. Its structure, the size of the axons it covers, and the molecular state of the oligodendrocytes can also be crucial for maintaining neuronal communication and cognition.

This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.